| Product NDC: | 55513-074 |
| Proprietary Name: | Sensipar |
| Non Proprietary Name: | cinacalcet hydrochloride |
| Active Ingredient(s): | 60 mg/1 & nbsp; cinacalcet hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55513-074 |
| Labeler Name: | Amgen Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021688 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040404 |
| Package NDC: | 55513-074-30 |
| Package Description: | 30 TABLET, COATED in 1 BOTTLE, PLASTIC (55513-074-30) |
| NDC Code | 55513-074-30 |
| Proprietary Name | Sensipar |
| Package Description | 30 TABLET, COATED in 1 BOTTLE, PLASTIC (55513-074-30) |
| Product NDC | 55513-074 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cinacalcet hydrochloride |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20040404 |
| Marketing Category Name | NDA |
| Labeler Name | Amgen Inc |
| Substance Name | CINACALCET HYDROCHLORIDE |
| Strength Number | 60 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA] |